FTSE falls on drug problem

clock •

The FTSE 100 is down 16.9 points, or 0.25%, to 6,619.9 in early trading, as suggestions a diabetes drug produced by GlaxoSmithKline increases the risk of heart attacks.

Broker downgrades following the reports mean GSK is the biggest loser so far with a fall of 3.24% to £13.45, closely followed by Marks & Spencer which has slipped 2.84% to 717.5p on a bout of profit-taking, after it revealed profit rose 28.5% but failed to reach £1bn mark. Experian is also down 1.33% to 595.5p, closely followed by Detica Group which has slipped 1.26% to 372p, while British Airways has dropped 1.25% to 474p, although Wolseley is limiting losses with a rise of 1.45% to £13.25. Alliance & Leicester is posting the biggest gains with a rise of 4.1% to £11.94, closely follow...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Economics / Markets

Fahad Hassan: When good news becomes an inflation problem

Fahad Hassan: When good news becomes an inflation problem

'Markets have been adjusting to the risks through valuations all year'

Fahad Hassan
clock 29 September 2026 • 6 min read
Healey promises 'new age of industrialisation' ahead of Budget

Healey promises 'new age of industrialisation' ahead of Budget

Keeps quiet on personal taxation, pensions or savings at Labour’s conference

Isabel Baxter
clock 28 September 2026 • 2 min read
MPs warn policymakers to stop using OBR as scapegoat for tough fiscal decisions

MPs warn policymakers to stop using OBR as scapegoat for tough fiscal decisions

Treasury Committee report

Jack Roach
clock 23 September 2026 • 2 min read